Literature DB >> 30762609

Reflux Symptoms in Gastroparesis: Correlation With Gastroparesis Symptoms, Gastric Emptying, and Esophageal Function Testing.

Asad Jehangir1, Henry P Parkman.   

Abstract

GOAL: The goal of this study was to determine the relationship of reflux with gastroparesis (Gp), looking both at symptoms and objective testing.
BACKGROUND: Gp patients often experience gastroesophageal reflux symptoms. How the severity of reflux correlates with the severity of Gp is not known. STUDY: Patients referred to our academic center with symptoms of Gp completed the Patient Assessment of Upper Gastrointestinal Symptoms, Hospital Anxiety and Depression Scale, and Patient Health Questionnaire (PHQ)-15. They underwent 4-hour gastric emptying scintigraphy; and, if indicated, high-resolution esophageal manometry and esophageal pH impedance (EpHI).
RESULTS: Of 755 patients from July 2013 to May 2018, 432 had Gp with Gastroparesis Cardinal Symptom Index (GCSI) total score of 3.2±0.1 (mean±SEM) and heartburn/regurgitation subscore of 2.0±0.1. A fourth (27.1%) of all Gp patients had moderate to very severe heartburn/regurgitation symptoms. Heartburn/regurgitation subscore had strong correlation with GSCI total score (r=0.56, P<0.01), and weak correlation with 4-hour gastric retention (r=0.11, P=0.02). In total, 103 Gp patients underwent EpHI monitoring; time esophageal pH<4 had no correlation with heartburn/regurgitation subscore. Less than half (41.7%) of the patients undergoing EpHI had gastroesophageal reflux disease by EpHI. Gp patients with gastroesophageal reflux disease had more severe 4-hour gastric retention, and more frequently had decreased lower esophageal sphincter resting pressure and esophageal motility disorders. Heartburn/regurgitation subscore had moderate correlation with somatic symptoms, and weak correlations with anxiety and depression.
CONCLUSIONS: The severity of reflux symptoms in Gp has strong correlation with GCSI total score, weak correlation with gastric retention, and no correlation with esophageal pH monitoring.

Entities:  

Mesh:

Year:  2020        PMID: 30762609     DOI: 10.1097/MCG.0000000000001190

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

1.  Pyloroplasty and the risk of Barrett's esophagus in patients with gastroparesis.

Authors:  Motasem Alkhayyat; Vedha Sanghi; Thabet Qapaja; Robert Butler; Carol Rouphael; John McMichael; John Goldblum; Madhusudhan R Sanaka; Prashanthi N Thota
Journal:  Dis Esophagus       Date:  2020-11-18       Impact factor: 3.429

Review 2.  Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet.

Authors:  David A Katzka; John E Pandolfino; Peter J Kahrilas
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-15       Impact factor: 11.382

Review 3.  A Comparative Assessment of the Diagnosis of Swallowing Impairment and Gastroesophageal Reflux in Canines and Humans.

Authors:  Tarini V Ullal; Stanley L Marks; Peter C Belafsky; Jeffrey L Conklin; John E Pandolfino
Journal:  Front Vet Sci       Date:  2022-06-09

4.  Evaluation of the pharmacokinetics of trazpiroben (TAK-906) in the presence and absence of the proton pump inhibitor esomeprazole.

Authors:  Jatinder Kaur Mukker; George Dukes; Lisi Wang; Susanna Huh; Polyna Khudyakov; Mitsuhiro Nishihara; Chunlin Chen
Journal:  Clin Transl Sci       Date:  2022-02-26       Impact factor: 4.438

5.  The pharmacokinetics of oral trazpiroben (TAK-906) after organic anion transporting polypeptide 1B1/1B3 inhibition: A phase I, randomized study.

Authors:  Jatinder K Mukker; George Dukes; Max Tolkoff; Lisi Wang; Cristina Almansa; Susanna Y Huh; Mitsuhiro Nishihara; Diane Ramsden; Chunlin Chen
Journal:  Clin Transl Sci       Date:  2022-05-05       Impact factor: 4.438

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.